Total cell-free DNA, carcinoembryonic antigen, and C-reactive protein for assessment of prognosis in patients with metastatic colorectal cancer

Medicin og biovidenskab

• Alleles 5%
• C-Reactive Protein 70%
• Carcinoembryonic Antigen 89%
• Cell-Free Nucleic Acids 100%
• Cetuximab 9%
• Clinical Decision-Making 8%
• Clinical Trials 5%
• Colorectal Neoplasms 63%
• Confidence Intervals 18%
• Control Groups 4%
• DNA 4%
• Everolimus 9%
• Irinotecan 9%
• Multivariate Analysis 5%
• Polymerase Chain Reaction 4%
• Progression-Free Survival 14%
• Reference Values 6%
• Regression Analysis 5%
• Serum 7%
• Shared Decision Making 9%
• Survival 22%
• Therapeutics 2%